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espite tke clinical a of ~~troglycer~~ sincet 
through venodi~ation, with subsequent preload reduction. 
recently, the arteriolar dilating actions f ~~trog~yce~~ 
been recognized (L-11). 
Although nitroglycerin has both preloa 
afterload-reducing actions, methods to predict its predomi- 
nant site of action in a given patient us8ing left ventricular 
pressure-volume relations have not been previously de- 
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and the relation of efIective arterial elastancc toend-systolic 
elasrance (E,/E,, ratio) before and after bolus intravenous 
nitroglycerin. 
Study patients. Twenty-seven patients were enrolled in 
this study, 24 men and 3 women with a mean age + SEM of 
57 + 4 years. Eighteen did not have a history of congestive 
heart failure (left ventricular ejection fraction 66 k 4%, range 
41% to 93%), and an additiunal nine patients had clinical 
congestive h art failure (New York Heart Association func- 
tional classes II to IV, left ventricular ejection fraction 24 + 
4% range 11% to 39%). Patients without aclinical history of 
congestive heart failure were referred for cardiac atheter- 
ization for a chest pain syndrome and had no history of 
congestive symptoms. Of these patients, eight had epicardial 
coronary artery disease and nine had a history of hyperten- 
sion, Of the patients with congestive h art failure, the cause 
was idiopathic dilated cardiomyopathy in four patients and 
ischemic ardiomyopathy in five. Three patients with and 
nine patients without congestive heart failure had a history 
of hypertension. All medications were withheld 18 h before 
cardiac catheterization, with the exception ofdiuretic agents 
in patients with congestive heart f ilure. Written informed 
consent was obtained from each patient, and the protocol 
was approved by the Human I vestigation Committee atthe 
University of Virginia. 
ata acquisition. Conductance catheter technique. A 
full description of the conductance atheter has been pub- 
lished elsewhere (14-16). The present study was performed 
with an 8F conductance catheter (W bster Labs) and, fully 
extended within its lumen, a 2F micromanometer catheter 
(Millar Instruments). The catheter is positioned under fluo- 
roscopic guidance along the long axis of the left ventricle and 
connected toa digital stimulator microprocessor (Sigma V, 
Leycom). The system uses a dual excitation algorithm and 
two pairs of stimulating electrodes ( ingle field). Resistance 
differences between i tervening electrode pairs are inversely 
related to segmental volumes, and individual segment vol- 
umes are summed to yield total chamber volume. Real-time 
pressure-volume loop display and two-channel analog/digital 
conversion (at 200 Hz) were performed using a 16-bit micro- 
computer system (Halcom, Inc). 
Protocol. Routine tight and left heart catheterization was 
performed with the Judkins technique. Nonionic contrast 
medium was used (Isovue, Squibb Diagnostics) to minimize 
negative inotropic effects. Fifteen minutes was allowed to 
elapse between coronary angiography and left ventriculog- 
raphy and initiation of the research protocol. Baseline he- 
nodynamic determinations, i cluding heart rate, pulmonary 
capillary wedge and left ventricular pressures, were re- 
corded. Five determinations of thermodilution cardiac out- 
put were made for later gain adjustments of conductance 
stroke volume. A 5-ml sample of v:nous blood was taken for 
baseline determination f blood resistivity (p). After ;lace- 
ment of’ the 8F conductance a illar catheters, as 
outlined eadier, an intravenous ~itroglyce~~ was 
administered by way of the femoral vein, and left v~~t~c~lar 
volume and pressure were recorded f~r 40 s on a beat by 
basis. 
Nirroglycerirt dose. The dose of ~itroglyce~~ was c 
sen so that drug administration resulted in at least a IS-mm 
Hg decrease insystolic arterial pressure. This dose of bolus 
intravenous. nitroglv&in was determined in p.reviou~ pilot I <, 
studies to be patients 
failure (Grocps 1 and 2a) and 4 
congestive h art failure, and e 
smoothed with a three-point, nonwe 
before hemodynamic variables were 
correction, the end-diastolic volume of the baseline co 
ce volume signal was set equal to the right anterior 
ique left v~~tric~lo~ram ebb-diastolic volume (19). For 
gain calibration, the conductance volume signal was multi- 
plied by the ratio of themodilution stroke volume and 
conductance stroke volume. 
The pressure-volume ramp used to generate end-systolic 
elastance began 1 beat preceding a visual decrease in pres- 
sure or volume and ended with the first beat of the nadir 
pressure or volume or baroreflex activation (defined as a 5% 
increase inheart rate on 3 consecutive b ats). All premature 
and postpremature beats were excluded from the analysis. 
Baseline end-diastolic volume, eflective arterial elastance 
and stroke volume were determined from the meam of 3 
consecutive beats immediately preceding this pressure- 
volume ramp. The effect of bolus nitroglycerin on end- 
diastolic volume, effective arterial elastance and stroke 
volume was determined at the nadir pressure or volume. If a 
reflex increase in heart rate occurred before nadir pressure 
or volume, then end-diastolic volume, effective arterial 
elastance and stroke volume were determined from the beat 
immediately before reflex activation. 
End-systolic elastance. The end-systolic pressure (P)- 
volume (V) point of ea:h loop was selected as the data point 
witkl the maximal pressure-volume ratio. A least-squares 
lilaear egression of those points was applied; generating 
slope (E,,) and intercept (Ye) estimate. With this estimate of
intercept, points of maximal P/V - V0 for each cycle were 
Figlnre 1. Calculation of effective arteriaE clastance (E,) on a beat by 
beat basis. Etfective arterial etastance is cakulated from the ratio of 
lefi ventricuPar (EV) end-systolic pressure @es) to stroke volume 
(SW for each pressure-volume relation. Bo this example. E,, > E,, 
because PC,* > PC,:. and SV, .C 561,. 
ined, and an iterative regression analysis was 
both slope and intercept remained cons&an&. 
ncr (Fig. I). Asterial elastance is 
ce, characteristic im- 
vasculanue. Because 
ominate. it is approximateiy 
vascular resistance and he 
ecause heart rate remains constant for all ~ressure~vo~~me 
relations analyzed for each patient, effective a 
elastance approximated systemic vascular resistance. 
tive arterial elastance was calculated fr0m the r 
end-systolic pressure (P,,) and stroke volume (SW. or E, = 
P,,ISV, as previously defined ( I2,&3, 
By representing arterial load as an ctive elaslic cham- 
ce allows arterial and ventricu- 
ed. Optimal effective arterial 
lastance has been previously 
defined as a ratio near unity (I?). For t 
patients were classified into groups according to their base- 
line EJE,, ratio. An EJE,, ratio >l .O was defined as 
excessive afterload for the level of ventricclar fmction. 
DeJinirioli qfpredomi~za~~ f preload 01’ irferload @err. To 
characterize the hemodynamic effects of bolus intravenous 
nitroglycerin, measurements of pretoad, afterload and stroke 
volume were made before and after nifroglycerin adminis- 
tration. Left ventricular preload was measured by lef& ven- 
tricular conductance end-diastolic volume. whereas left ven- 
tricular afterload was measured by effective arterial 
elastance. In some patients, both preload and afterioad were 
reduced after bolus intraversous nitr$: ~3-jii admiaistra- 
tion_, To A;:--- - UbLmnme wbicb xiuct:Gr, predxicared i cah- 
brated conductance stroke voiume was utilized. A decrease 
in preload was considered predominant if stroke volume 
Fi:?er exact test. Id 
et-4 significant at a 
1). Patients were strat- 
’ ‘nitial E,IE,, ratio. Group 
r level of ventricular fkW;&ion. Group 2 (II = 1 
ned as those patients with an E 
mg tkose with excessive afterload 
hcongcstivc beai-t failure) Cd; 
of patients in all three groups were treat 
channel blocking agents, beta-adrenergic 
and long-acting oral nitrate 
cations at least 18 h before 
Group 2b &han in either 
angiotensin-converting e 
tricular systolic function, as indicated by both left ventricu- 
lar ejection fraction and e 
in patients in Group 1. tients in Group 2a 
effective values for arterial elastance than di 
Group 1. consisten& with their 
ut they had lower 
in Group I. Patienfts in Group 2b ha 
heart rate and pulmonary wedge pressed, lower va!ues for 
left ventricular ejection fractions and end-systolic elastance 
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Table 2. Baseline Fknwdynamic and Clinical Characteristics of Patients in the Three Study Groups 
- 
HR PCW LVSP EF E k 
Study Group (beats/min) (mm Hg) (mm Hg) (%) (mm $/ml) (mm Hglml) HTN CHF 
- 
l(EJE,,<l)(n=9) 6824 14 2 2 142 ” 6 69 t 4 2.25 2 0.22 1.57 -t 0.15 2 (22) 0 (0) 
ia (E&E,, > I; EF > 40%) (n = 9) 14 ? 3 13 + 1 IS9 -L 9 57 2 3 1.49 ?I 0.12* 2.15 ? 0.45* 8 (88)* 0 (0) 
2b (EJE,, > 1; EF < 40%) (n = 9) 88 c 3* 26 f 4* 128 ? 7 24 2 4% 0.77 i: 0.22*t 3.70 f 0.36’ 3 (331 9 (loo)*t 
_. 
*p < 0.005 versus Group 1. tp < 0.016 versus Group 2a. Values are expressed as mean value k SEM or number (%) of patients. CHF = congestive heart 
failure; HR = heart rate; HTN = hypertension; LVSP = left ventricular systolic pressure; PCW = pulmonary capillary wedge pressure; other abbreviations as 
in Table 1. 
and higher values for effective arteriai elastance than did 
patients inother groups. 
Wemodynamic response to bolus nitroglycerin (Table 3, 
Fig. 2). Changes in left ventricular end-diastolic volume 
(preload) were different in all three groups (p = 0.04 by 
ANOVA). EnId-diastolic volume was reduced most in Group 
I, least in Group 2a and to an intermediate extent rn Group 
2b. Changes in effective arterial elastance (afterload) were 
also different in all three groups (p = 0.01 by ANOVA). 
Effective arterial elastance was reduced most in Groups 2b 
and 2a and least in Group I. Changes in stroke volume 
differed in all three groups (p = 0.04 by ANOVA). Stroke 
volume was only reduced in Group I and was increased most 
in Group 2a and to a lesser degree in Group 2b. Reductions 
in systolic blood pressure differed in all three groups (p = 
0.05 by ANOVA). Systolic blood pressure was reduced most 
in Groups 2a and 1 and least in Group 2b. Thus, patients with 
a baseline EJE,, ratio <I (Group I) demonstrated a predom- 
inant preload reduction but only a modest afterload re uc- 
tion. In contrast, patients with an E,IE,, ratio >I and normal 
or mildly depressed left ventricular eje&n fraction (Group 
2a) demonstrated a predominant af erload reduction but only 
a modest preload reduction. Finally, patients with an E&/E,, 
ratio >I atzd low left ventricular ejection fraction (Group 2b) 
demonstrated significant preload and afterload reductions 
after bolus injection of intravenous nitroglycerin, but the 
afterload reduction was predominant, asindicated by an 
increase in stroke volume. A representative example of 
pressure-volume relations after boius intravenous adminis- 
tration of nitroglycerin for a patient i  each group is shown 
in Figure 3. 
iscussim 
In the present study, patients with an initial EJE,, ratio 
<I (Group I) constituted a group of normotensive patients 
with intact systolic function who exhibited a predominant 
preload reduction, with a decrease in stroke volume in 
response to bolus i 
erin. Those with a 
moderately reduced systolic frmction (Gr 
a group of patients, most of whom were 
had a predominant afterload reduction with an increase in 
stroke volume after bolus administration of 
Finally, those with an initial EJE,, ratio >1 
left ventricular ejection fraction (Group 2b) 
group of patients with clinical congestive heart f ilure who 
exhibited a reduction i  both preload and afterload in re- 
sponse to bolus administration of itroglycerin but with a 
predominant reduction i afterload with an inc 
volume. Thus, the transient hemody~amic res
intravenous administration f nitroglycerin be 
vation of reflexes can be predicted by the baseline r lation of 
afterload to end-systolic elastance and by a clinical charac- 
terization (i.e., normotensivz ersus hypertensive rsus 
congestive heart ure). Few other studies have tested the 
utilit;r of the ctivc arterial elastancelend-systolic 
elzstprlce ratio in normal (20) and abnormal (21) circulations. 
Vasodilator therapy for the treatment. of congestive heart 
failure gained initial popularity with the appreciation that he 
failing left ventricle is exquisitely sensitive to afterload, 
whereas the normal left ventricle can adjust its contractile 
state to eject against higher afterload (22,23). Patients in 
Group 1 had a decrease in stroke volume in response to a 
decrease in preload (end-diastolic volume). This Ending 
confirms the dependence of ventricles with normal contrac- 
tility on the Frank-Starling mechanism, or the preload sen- 
sitivity of stroke volume. Our study also demonstrated that 
ventricles with depressed contractility are primarily after- 
load dependent. Patients in Group Zb, who had a clinical 
history of congestive h art failure, had an increase in stroke 
volume in response to a decrease in afterload (E,) despite a
Table 3. Hemodynamic Responses to Intravenous I3olus Administration of Nitroglycerin 
S!udy Group 
E, 
EDV (ml) (mm Hdml) SV (ml) 
I(EaE,, < I) (n = 9) 
LVSP (mm Hg) 
-22 AI 7 -0.32 f 0.07 -5 i 4 -30 r 4 
2a (EJE,, > 1: EF > 40%) (n = 9) -4 t- 4* --1.20 ? 0.29* 20 2 6” -38 2 6 
2b (EJE,, > 1; EF < 40%) (n = 9) -11 t3 - 1.26 + 0.26* 9 + 3* -20 f 4t 
- 
*p < 0.016 versus Group I. tp < 0.016 versus Group 2a. Values are expressed as mean value + SEM. EDV = 
end-diastok volume; LVSP = left ventricular systolic pressure; SV = stroke vokee: other abbreviations as in 
Tables I and 2. 
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* ejection fraction 
. Preioad changes, defined 
se in end-diastolic volume 
effective arterial elastance (E,), are 
greatest in Groups 2a and 2b. In- 
cre2ses in stroke volume (SV) consis- 
tent with a predominant afterload ef- 
fect are seen in Groups 2a and Zb. 
Systolic blood pressure (BP) de- 
creased in all grolnps but to a lesser 
extent in Group 2b. *p < 0.05 vs. 
Group 1. t 
decrease in yreload. This o 
dence of the stroke volume 
increase most in 
comparable between the two groups, it is possible 
Gmup 1 Group 20 Group 2b 
ere are seve 
re 3. representative examples of left ver~t~c~~ar (LV) pressure- 
volume relations obtained 
nitroglycerin. The patient 
large decrease in end-diastolic volume 
stroke volume (SW from the fi 
from Group 2a (E,/E,, 
reduction in end-diasroli 
e from the first GV,) to 
Group 2b 0$,/E;,,, > I; ejection 
tion in end-diastolic volume and an increase in stroke vollame from 
the first (SV,) to the final (SV,) beat. 
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from tile conductance atheter and assumed that he volume 
corrections for both offset and gain were load independent. 
Previous investigators (24,25) have shown that, aiher than 
being const.ants, t&h the offset and gain corrections may 
vary somewhat svolume changes. Furthermore, the use of 
thermodilution-derived stroke volume for gain correction 
may be inaccurate in patients with depressed left ventricular 
function (26,27). Despite such limitations, conductance voi- 
ume measurements arestill of value in physiologic studies 
requiring relative rather than absolute volume measurements 
(25,26)* 
2) Nitroglycerin differed in Group 2b from that in Groups 
I and 2~ It has previously been shown (29,30) that low-dose 
nitrates primarily affect venous capacitance vessels, 
whur-:as higher dose nitrates affect the arterial system. To be 
certain that the response of Group 2b was not due to the 
higher bolus dose of nitroglycerin administered, an addi- 
tional three patients with clinical heart failure (left ventricu- 
lar ejection fraction 23% to 37%) were given both 200- and 
40O-~~g doses of bolus intravenous nitroglycerin. In these 
three patients, both 2OQ- and 400~pg doses of intravenous 
mtrogiycerin produced qualitatively similar hemsdynamic 
effects, with reductions in preioad and afterload and with 
predominant afterload reductions because stroke volume 
increased. These data suggest that although patients In 
Group 2b received a larger dose of nitroglycerin than that 
of other patients, the predominant preioad or afterload 
effects demonstrated in these patients were not due to 
this higher dose. Nevertheless, it is possible that even 
higher doses of boius intravenous nitroglycerin might 
have shown a qualitatively different hemodynamic elect 
from that demonstrated at the doses used in the present 
study. 
3) Patients did not achieve asteady state cardiovascular 
response tobolus intrctveaous nitroglycerin at the time of our 
measurements. This factor is relevant because caicuiations 
of end-diastolic volume and eRertr;ve arterial elastance after 
boius intravenous nitroglycerin were made in non-steady 
state conditions. Despite this limitation, there car, be no 
doubt that both Group? 2a and 2b had predominant de- 
creases ineffective arterial eiastance b cause stroke volume 
increased. Our conclusions are therefore still valid. Further- 
more, the effects of nitrates on the peripheral circulation can 
be affected by reflex activation. Vatner et al. (3 I) previously 
demonstrated hat cardiac output may initially increase after 
nitrate administration but subsequently decrease because of
reflex activation. A goal of the present study was to circum- 
vent his difficulty by attempting to obtain all hemodynamic 
measurements before the onset of reflex activation, how- 
ever, reflex activation apart from that observed by a reflex 
increase inheart rate may have cccurred. 
Conclusions. The predominant hemodynamic effect of 
bolus intravenous nitroglycerin may be predicted by the 
baseline r lation of afterload toventricular &unction. Patients 
with excessive afterload for their level of left vent~cui~ 
function (E,& ratio >l) develop a predominant f erload 
reduction i response tonit@ ,.yccrIi~ In contrast, mit~og~yc- 
erin xkinisiration results in apredominant prelo 
tion in patients whose afterload 
level of left vectricuiar function ( 
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